Related Experiment Video
Updated: Jan 18, 2026

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
Comorbidity and modifiable risk factors in multiple sclerosis
Yao Zhang1, Ruth Dobson2,3, Gavin Giovannoni4
1Peking Union Medical College Hospital, Beijing, China.
Abstract:
Multi-system comorbidities are common in patients with multiple sclerosis (PwMS) and significantly influence the disease's presentation and progression. A comorbidity is defined as an illness other than the specific disease of interest (in this case, MS). Generally, chronic or recurrent conditions are included, while transient conditions such as infection or concussion are excluded. Certain modifiable metabolic diseases in PwMS, such as hypertension, diabetes, dyslipidemia, and modifiable health factors such as smoking, alcohol, and obesity, are also considered part of MS comorbidity in this review, since these are risk factors not only for poor outcomes in MS but also for other vascular comorbidities in PwMS. Cohort studies and clinical trials have reported that comorbidity could have multiple adverse effects on MS. The purpose of this review is to summarize studies investigating modifiable risk factors of comorbidity of MS, as well as multiple body system comorbidities in MS, focusing on the influence these comorbidities have on MS outcomes. We aim to emphasize that the management of MS involves not only disease-modifying therapy, but also requires controlling and preventing modifiable risk factors for comorbidities and appropriate treatment of comorbidities, as these interventions may be equally crucial in improving the prognosis of MS.
Insights
Comorbidities significantly impact multiple sclerosis (MS) progression. Managing MS effectively requires addressing these co-occurring conditions and their modifiable risk factors alongside disease-modifying therapies for improved patient outcomes.
Area of Science:
- Neurology
- Immunology
- Public Health
Background:
- Multi-system comorbidities are prevalent in patients with multiple sclerosis (PwMS).
- Comorbidities, defined as conditions separate from MS, significantly affect disease presentation and progression.
- Modifiable factors like hypertension, diabetes, dyslipidemia, smoking, alcohol use, and obesity are considered MS comorbidities due to their impact on MS and vascular health.
Purpose of the Study:
- To review studies on modifiable risk factors for comorbidities in MS.
- To examine the influence of multi-system comorbidities on MS outcomes.
- To highlight the importance of managing comorbidities and their risk factors in MS care.
Main Methods:
- Systematic review of cohort studies and clinical trials.
- Analysis of research investigating modifiable risk factors and their association with MS comorbidities.
- Synthesis of findings on the impact of comorbidities on MS progression and outcomes.
Main Results:
- Comorbidities are associated with adverse effects on multiple sclerosis.
- Modifiable risk factors contribute to the development of comorbidities in PwMS.
- Effective management of comorbidities and risk factors is crucial for improving MS prognosis.
Conclusions:
- Comprehensive MS management necessitates addressing comorbidities and modifiable risk factors.
- Interventions targeting comorbidities and risk factors are vital for enhancing MS prognosis.
- Integrated care approaches are essential for optimizing outcomes in patients with multiple sclerosis and comorbidities.
More Related Videos
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
09:46Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
Related Concept Videos
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Coronary Artery Disease I: Introduction
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Atherosclerosis III: Management
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...